• General Dermatology
  • Eczema
  • Alopecia
  • Aesthetics
  • Vitiligo
  • COVID-19
  • Actinic Keratosis
  • Precision Medicine and Biologics
  • Rare Disease
  • Wound Care
  • Rosacea
  • Psoriasis
  • Psoriatic Arthritis
  • Atopic Dermatitis
  • Melasma
  • NP and PA
  • Anti-Aging
  • Skin Cancer
  • Hidradenitis Suppurativa
  • Drug Watch
  • Pigmentary Disorders
  • Acne
  • Pediatric Dermatology
  • Practice Management

Updates in the Medicine Chest


In a video with Dermatology Times®, James Q. Del Rosso, DO, discusses his presentation “What’s News in the Medicine Chest” at the current 2022 Fall Clinical Dermatology Conference for PAs & NPs.

From oral apremilast (Otezla; Amgen Inc) to tapinarof (Dermavant Sciences) and roflumilast (Arcutis Biotherapeutics), James Q. Del Rosso, DO, research director of JDR Dermatology Research in Las Vegas, Nevada and senior vice president of clinical research and strategic development at Advanced Dermatology & Cosmetic Surgery in Maitland, Florida, highlighted updates in the health care professional’s armamentarium for dermatology at the current Fall Clinical Dermatology Conference for PAs & NPs, held June 3 to 5, 2022 in Scottsdale, Arizona.

Related Videos
© 2024 MJH Life Sciences

All rights reserved.